Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R61/R33HL133943)
Received: 7 February 2022
Accepted: 30 May 2022
First Online: 15 June 2022
: Institutional review board approval was obtained from VCU prior to the start of the trial. IRB HM20014686; initial approval date: 11/19/2018.
: Not applicable.
: Dr. Abbate (AA) has served as consultant to Swedish Orphan Biovitrum in the past. Dr. Van Tassell (BVT) has served as consultant to Swedish Orphan Biovitrum in the past. No other authors have relevant disclosures.